50
SALT LAKE CITY, UT — November 4, 2025 — Leads & Copy — Utah Medical Products, Inc. (Nasdaq:UTMD) has appointed Kevin C. Timken, Esq to its Board of Directors, the company announced today. Mr. Timken served as UTMD’s outside legal counsel for over twenty years before retiring in 2025.
The Board of Directors also approved a quarterly cash dividend of $0.31 per share, payable on January 5, 2026, to shareholders of record on December 16, 2025. This is a 1.6% increase over the previous quarterly dividend.
Utah Medical Products, Inc. develops, manufactures, and markets specialty medical devices for women’s and infant health care.
Contact: Brian Koopman, (801) 566-1200
Source: Utah Medical Products, Inc.
Source: Utah Medical Products, Inc.
